pharmpact ltd
pharmpact ltd Company Information
Company Number
08313467
Website
www.ennogen.comRegistered Address
unit g4, riverside industrial estate rive, dartford, kent, DA1 5BS
Industry
Operation of warehousing and storage facilities for land transport activities of division 49
Telephone
01322629220
Next Accounts Due
September 2024
Group Structure
View All
Directors
Gurdev Ruprai11 Years
Shareholders
gurdev singh ruprai 100%
pharmpact ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMPACT LTD at £42.6k based on a Turnover of £100.3k and 0.43x industry multiple (adjusted for size and gross margin).
pharmpact ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMPACT LTD at £1.2m based on an EBITDA of £360.5k and a 3.35x industry multiple (adjusted for size and gross margin).
pharmpact ltd Estimated Valuation
Pomanda estimates the enterprise value of PHARMPACT LTD at £0 based on Net Assets of £-72.8k and 2.04x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmpact Ltd Overview
Pharmpact Ltd is a live company located in dartford, DA1 5BS with a Companies House number of 08313467. It operates in the operation of warehousing and storage facilities for land transport activities sector, SIC Code 52103. Founded in November 2012, it's largest shareholder is gurdev singh ruprai with a 100% stake. Pharmpact Ltd is a established, micro sized company, Pomanda has estimated its turnover at £100.3k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmpact Ltd Health Check
Pomanda's financial health check has awarded Pharmpact Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £100.3k, make it smaller than the average company (£10.6m)
- Pharmpact Ltd
£10.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (6.6%)
- Pharmpact Ltd
6.6% - Industry AVG
Production
with a gross margin of 34.7%, this company has a comparable cost of product (34.7%)
- Pharmpact Ltd
34.7% - Industry AVG
Profitability
an operating margin of 343.4% make it more profitable than the average company (6.4%)
- Pharmpact Ltd
6.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (60)
- Pharmpact Ltd
60 - Industry AVG
Pay Structure
on an average salary of £38.2k, the company has an equivalent pay structure (£38.2k)
- Pharmpact Ltd
£38.2k - Industry AVG
Efficiency
resulting in sales per employee of £100.3k, this is less efficient (£154.9k)
- Pharmpact Ltd
£154.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmpact Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 87 days, this is slower than average (37 days)
- Pharmpact Ltd
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmpact Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (12 weeks)
1 weeks - Pharmpact Ltd
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 105.5%, this is a higher level of debt than the average (59.7%)
105.5% - Pharmpact Ltd
59.7% - Industry AVG
PHARMPACT LTD financials
Pharmpact Ltd's latest turnover from December 2022 is estimated at £100.3 thousand and the company has net assets of -£72.8 thousand. According to their latest financial statements, we estimate that Pharmpact Ltd has 1 employee and maintains cash reserves of £20 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 844,911 | 861,022 | 877,272 | 892,272 | 907,272 | 922,272 | 937,272 | 951,572 | 192,000 | 196,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 844,911 | 861,022 | 877,272 | 892,272 | 907,272 | 922,272 | 937,272 | 951,572 | 192,000 | 196,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44,640 | 5,526 | 6,795 |
| Group Debtors | 0 | 0 | 0 | 0 | 442,382 | 450,480 | 978,480 | 0 | 0 | 0 |
| Misc Debtors | 457,456 | 507,692 | 540,631 | 629,368 | 0 | 0 | 0 | 149,313 | 0 | 0 |
| Cash | 20,017 | 17,122 | 31,524 | 27,329 | 26,345 | 830,238 | 50,410 | 5,336 | 27,606 | 35,373 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 477,473 | 524,814 | 572,155 | 656,697 | 468,727 | 1,280,718 | 1,028,890 | 199,289 | 33,132 | 42,168 |
| total assets | 1,322,384 | 1,385,836 | 1,449,427 | 1,548,969 | 1,375,999 | 2,202,990 | 1,966,162 | 1,150,861 | 225,132 | 238,168 |
| Bank overdraft | 55,452 | 55,159 | 55,000 | 55,000 | 55,000 | 55,000 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 15,673 | 4,380 | 11,562 | 16,147 | 14,810 | 14,476 | 3,848 | 0 | 101,926 | 81,291 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 230,280 | 230,280 | 183,600 | 176,383 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 795,674 | 1,082,899 | 1,079,611 | 1,097,601 | 70,452 | 54,705 | 46,437 | 32,768 | 0 | 0 |
| total current liabilities | 866,799 | 1,142,438 | 1,146,173 | 1,168,748 | 370,542 | 354,461 | 233,885 | 209,151 | 101,926 | 81,291 |
| loans | 528,434 | 550,000 | 605,000 | 660,000 | 1,224,396 | 1,954,002 | 1,744,442 | 954,442 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 150,000 | 150,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 528,434 | 550,000 | 605,000 | 660,000 | 1,224,396 | 1,954,002 | 1,744,442 | 954,442 | 150,000 | 150,000 |
| total liabilities | 1,395,233 | 1,692,438 | 1,751,173 | 1,828,748 | 1,594,938 | 2,308,463 | 1,978,327 | 1,163,593 | 251,926 | 231,291 |
| net assets | -72,849 | -306,602 | -301,746 | -279,779 | -218,939 | -105,473 | -12,165 | -12,732 | -26,794 | 6,877 |
| total shareholders funds | -72,849 | -306,602 | -301,746 | -279,779 | -218,939 | -105,473 | -12,165 | -12,732 | -26,794 | 6,877 |
| Dec 2022 | Dec 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 16,111 | 16,250 | 15,000 | 15,000 | 15,000 | 15,000 | 14,300 | 7,100 | 4,000 | 4,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -50,236 | -32,939 | -88,737 | 186,986 | -8,098 | -528,000 | 784,527 | 188,427 | -1,269 | 6,795 |
| Creditors | 11,293 | -7,182 | -4,585 | 1,337 | 334 | 10,628 | 3,848 | -101,926 | 20,635 | 81,291 |
| Accruals and Deferred Income | -287,225 | 3,288 | -17,990 | 1,027,149 | 15,747 | 8,268 | 13,669 | 32,768 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | -230,280 | 0 | 46,680 | 7,217 | 176,383 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -21,566 | -55,000 | -55,000 | -564,396 | -729,606 | 209,560 | 790,000 | 954,442 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -150,000 | 0 | 150,000 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 2,895 | -14,402 | 4,195 | 984 | -803,893 | 779,828 | 45,074 | -22,270 | -7,767 | 35,373 |
| overdraft | 293 | 159 | 0 | 0 | 0 | 55,000 | 0 | 0 | 0 | 0 |
| change in cash | 2,602 | -14,561 | 4,195 | 984 | -803,893 | 724,828 | 45,074 | -22,270 | -7,767 | 35,373 |
pharmpact ltd Credit Report and Business Information
Pharmpact Ltd Competitor Analysis
Perform a competitor analysis for pharmpact ltd by selecting its closest rivals, whether from the TRANSPORTATION AND STORAGE sector, other micro companies, companies in DA1 area or any other competitors across 12 key performance metrics.
pharmpact ltd Ownership
PHARMPACT LTD group structure
Pharmpact Ltd has no subsidiary companies.
Ultimate parent company
PHARMPACT LTD
08313467
pharmpact ltd directors
Pharmpact Ltd currently has 1 director, Mr Gurdev Ruprai serving since Nov 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Gurdev Ruprai | 64 years | Nov 2012 | - | Director |
P&L
December 2022turnover
100.3k
+258%
operating profit
344.4k
0%
gross margin
34.7%
+3.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-72.8k
-0.76%
total assets
1.3m
-0.05%
cash
20k
+0.17%
net assets
Total assets minus all liabilities
Similar Companies
pharmpact ltd company details
company number
08313467
Type
Private limited with Share Capital
industry
52103 - Operation of warehousing and storage facilities for land transport activities of division 49
incorporation date
November 2012
age
12
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
unit g4, riverside industrial estate rive, dartford, kent, DA1 5BS
last accounts submitted
December 2022
pharmpact ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmpact ltd.
pharmpact ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
